These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 7135387)

  • 1. [Kinetics of the in vitro dissolution of cadmium oxide particles in human plasma and cadmium binding to plasma proteins--effect of chelating agents].
    Frenet M; Vincent F; Boiteau HL
    Toxicol Eur Res; 1982 May; 4(3):135-41. PubMed ID: 7135387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro dissolution of metallic oxides in human plasma and binding of metals to plasma proteins--effect of chelators].
    Frenet M; Vincent F; Boiteau HL
    Toxicol Eur Res; 1983 May; 5(3):131-9. PubMed ID: 6636166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro assessment of chelating agents with regard to their abstraction efficiency of Cd(2+) bound to plasma proteins.
    Zeini Jahromi E; Gailer J
    Metallomics; 2012 Aug; 4(9):995-1003. PubMed ID: 22820874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary deposition, clearance and effects of inhaled soluble and insoluble cadmium compounds.
    Oberdörster G
    IARC Sci Publ; 1992; (118):189-204. PubMed ID: 1303941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biliary excretion of cadmium in rat. III. Effects of chelating agents and change in intracellular thiol content on biliary transport and tissue distribution of cadmium.
    Cherian MG
    J Toxicol Environ Health; 1980 Mar; 6(2):379-91. PubMed ID: 7392099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive determination of plasma protein binding of cationic drugs using mixed-mode solid-phase microextraction.
    Peltenburg H; Bosman IJ; Hermens JL
    J Pharm Biomed Anal; 2015 Nov; 115():534-42. PubMed ID: 26313333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative effectiveness of some chelating agents as antidotes in acute cadmium poisoning.
    Jones MM; Weaver AD; Weller WL
    Res Commun Chem Pathol Pharmacol; 1978 Dec; 22(3):581-8. PubMed ID: 216066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cadmium inhibits delta-aminolevulinate dehydratase from rat lung in vitro: interaction with chelating and antioxidant agents.
    Luchese C; Zeni G; Rocha JB; Nogueira CW; Santos FW
    Chem Biol Interact; 2007 Jan; 165(2):127-37. PubMed ID: 17187767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a new chelating agent for cadmium: a preliminary report.
    Gulumian M; Casimiro E; Linder PW; Rama DB; Hancock RD
    Hum Exp Toxicol; 1993 May; 12(3):247-51. PubMed ID: 8100436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the toxicology of carbromal. IV. Binding of carbromal and its hypnotically active metabolites to human plasma proteins (author's transl)].
    Vohland HW; Streichert B
    Arch Toxicol; 1978 Oct; 41(1):69-77. PubMed ID: 31154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chelating agents and solubility of cadmium complexes on uptake from soil by Brassica juncea.
    Van Engelen DL; Sharpe-Pedler RC; Moorhead KK
    Chemosphere; 2007 Jun; 68(3):401-8. PubMed ID: 17320931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of chelating agents on the mobilization of cadmium: a mechanistic approach.
    Srivastava RC; Gupta S; Ahmad N; Hasan SK; Farookh A; Husain MM
    J Toxicol Environ Health; 1996 Feb; 47(2):173-82. PubMed ID: 8598573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MS-325: albumin-targeted contrast agent for MR angiography.
    Lauffer RB; Parmelee DJ; Dunham SU; Ouellet HS; Dolan RP; Witte S; McMurry TJ; Walovitch RC
    Radiology; 1998 May; 207(2):529-38. PubMed ID: 9577506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro assessment of cobalt oxide particle dissolution in simulated lung fluids for identification of new decorporating agents.
    Van Der Meeren A; Lemaire D; Coudert S; Drouet G; Benameur M; Gouzerh C; Hee CY; Brunquet P; Trochaud B; Floriani M; Gateau C; Lebrun C; Delangle P; Berthomieu C; Malard V
    Toxicol In Vitro; 2020 Aug; 66():104863. PubMed ID: 32304792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro and in vivo effect of cadmium microparticles on antibody receptors of alveolar macrophage membranes].
    de Hung Vo Phi ; Bouley G; Boudene C
    C R Seances Acad Sci III; 1981 Dec; 293(13):697-700. PubMed ID: 6802445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilocarpine inactivation.
    Schonberg SS; Ellis PP
    Arch Ophthalmol; 1969 Sep; 82(3):351-5. PubMed ID: 4979837
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro binding of amantadine to plasma proteins.
    Liu P; Cheng PJ; Ing TS; Daugirdas JT; Jeevanandhan R; Soung LS; Galinis S
    Clin Neuropharmacol; 1984; 7(2):149-51. PubMed ID: 6733694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination and metabolism of dithiol chelating agents: X. In humans, meso-2,3-dimercaptosuccinic acid is bound to plasma proteins via mixed disulfide formation.
    Maiorino RM; Akins JM; Blaha K; Carter DE; Aposhian HV
    J Pharmacol Exp Ther; 1990 Aug; 254(2):570-7. PubMed ID: 2166796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro binding and pharmacokinetics of gold salts in plasma proteins and chelating agents.
    Biggs DF; Boland DM; Davis P; Wakaruk J
    J Rheumatol Suppl; 1979; 5():68-73. PubMed ID: 114650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Methods of determination and theoretical principles of the serum protein binding of drugs (author's transl)].
    Scholtan W
    Arzneimittelforschung; 1978; 28(7):1037-47. PubMed ID: 385005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.